Knock-down of POSH expression is neuroprotective through down-regulating activation of the MLK3-MKK4-JNK pathway following cerebral ischaemia in the rat hippocampal CA1 subfield

Journal of Neurochemistry

Volumn 95, Issue 3, 2005, Pages 784-795

  Zhang, Quan Guang ^a,b   Wang, Rui Min ^b   Yin, Xiao Hui ^b   Pan, Jing ^b   Xu, Tian Le ^a,c   Zhang, Guang Yi ^a,b  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^b XUZHOU MEDICAL UNIVERSITY   (China)

^c Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

Author keywords

Antisense oligodeoxynucleotides; c Jun N terminal kinase; Hippocampus; MAP kinase kinase 4; Mixed lineage kinase 3; Neuronal death

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MIXED LINEAGE KINASE 3; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; BRAIN PERFUSION; BRAIN REGION; CELL DENSITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOSOL; DOWN REGULATION; ENZYME ACTIVATION; ENZYME INHIBITION; GRANULE CELL; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BRAIN ISCHEMIA; CASPASE 3; CASPASES; DOWN-REGULATION; HIPPOCAMPUS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MAP KINASE KINASE 4; MAP KINASE KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; PYRAMIDAL CELLS; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 27644433927     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2005.03435.x     Document Type: Article

References (42)

1. Chen J., Nagayama T., Jin K., Stetler R. A., Zhu R. L., Graham S. H. and Simon R. P. (1998) Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia. J. Neurosci. 18, 4914-4928.
2. Chen J., Zhu R. L., Nakayama M., Kawaguchi K., Jin K., Stetler R. A., Simon R. P. and Graham S. H. (1996) Expression of the apoptosis-effector gene, Bax, is up-regulated in vulnerable hippocampal CA1 neurons following global ischemia. J. Neurochem. 67, 64-71.
3. Davis R. J. (2000) Signal transduction by the JNK group of MAP kinases. Cell 103, 239-252.
4. Dluzniewska J., Beresewicz M., Wojewodzka U., Gajkowska B. and Zablocka B. (2005) Transient cerebral ischemia induces delayed proapoptotic Bad translocation to mitochondria in CA1 sector of hippocampus. Brain Res. Mol. Brain Res. 133, 274-280.
5. Figueroa C., Tarras S., Taylor J. and Vojtek A. B. (2003) Akt2 negatively regulates assembly of the POSH-MLK-JNK signaling complex. J. Biol. Chem. 278, 47 922-47 927.
6. Gallo K. A., Mark M. R., Scadden D. T., Wang Z., Gu Q. and Godowski P. J. (1994) Identification and characterization of SPRK, a novel src-homology 3 domain-containing proline-rich kinase with serine/threonine kinase activity. J. Biol. Chem. 269, 15 092-15 100.
7. Gelderblom M., Eminel S., Herdegen T. and Waetzig V. (2004) c-Jun N-terminal kinases (JNKs) and the cytoskeleton - functions beyond neurodegeneration. Int. J. Dev. Neurosci. 22, 559-564.
8. Gu Z., Jiang Q., Zhang G., Cui Z. and Zhu Z. (2000) Diphosphorylation of extracellular signal-regulated kinases and c-Jun N-terminal protein kinases in brain ischemic tolerance in rat. Brain Res. 860, 157-160.
9. Gu Z., Jiang Q. and Zhang G. (2001a) c-Jun N-terminal kinase activation in hippocampal CA1 region was involved in ischemic injury. Neuroreport 12, 897-900.
10. Gu Z., Jiang Q. and Zhang G. (2001b) Extracellular signal-regulated kinase 1/2 activation in hippocampus after cerebral ischemia may not interfere with postischemic cell death. Brain Res. 901, 79-84.
11. Gupta S., Barrett T., Whitmarsh A. J., Cavanagh J., Sluss H. K., Derijard B. and Davis R. J. (1996) Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J. 15, 2760-2770.
12. Im J. Y., Lee K. W., Kim M. H. et al. (2003) Repression of phospho-JNK and infarct volume in ischemic brain of JIP1-deficient mice. J. Neurosci. Res. 74, 326-332.
13. Irving E. A. and Bamford M. (2002) Role of mitogen- and stress-activated kinases in ischemic injury. J. Cereb. Blood Flow Metab. 22, 631-647.
14. Karin M. (1995) The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270, 16 483-16 486.
15. Kuan C. Y., Yang D. D., Samanta Roy D. R., Davis R. J., Rakic P. and Flavell R. A. (1999) The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development. Neuron 22, 667-676.
16. Leung I. W. and Lassam N. (2001) The kinase activation loop is the key to mixed lineage kinase-3 activation via both autophosphorylation and hematopoietic progenitor kinase 1 phosphorylation. J. Biol. Chem. 276, 1961-1967.
17. Li C. H., Wang R. M., Zhang Q. G. and Zhang G. Y. (2005) Activated mitogen-activated protein kinase kinase 7 redistributes to the cytosol and binds to Jun N-terminal kinase-interacting protein 1 involving oxidative stress during early reperfusion in rat hippocampal CA1 region. J. Neurochem. 93, 290-298.
18. Lowry O. H., Rosebrough N. J., Farr A. L. and Randall R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
19. Matsuoka Y., Okazaki M., Zhao H., Asai S., Ishikawa K. and Kitamura Y. (1999) Phosphorylation of c-Jun and its localization with heme oxygenase-1 and cyclooxygenase-2 in CA1 pyramidal neurons after transient forebrain ischemia. J. Cereb. Blood Flow Metab. 19, 1247-1255.
20. McDonald P. H., Chow C. W., Miller W. E., Laporte S. A., Field M. E., Lin F. T., Davis R. J. and Lefkowitz R. J. (2000) β-Arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3. Science 290, 1574-1577.
21. Muller G. J., Stadelmann C., Bastholm L., Elling F., Lassmann H. and Johansen F. F. (2004) Ischemia leads to apoptosis - and necrosis-like neuron death in the ischemic rat hippocampus. Brain Pathol. 14, 415-424.
22. Nozaki K., Nishimura M. and Hashimoto N. (2001) Mitogen-activated protein kinases and cerebral ischemia. Mol. Neurobiol. 23, 1-19.
23. Ogita K. and Yoneda Y. (1994) Selective potentiation of DNA binding activities of both activator protein 1 and cyclic AMP response element binding protein through in vivo activation of N-methyl-D-aspartate receptor complex in mouse brain. J. Neurochem. 63, 525-534.
24. Pan J., Zhang Q. G. and Zhang G. Y. (2005) The neuroprotective effects of K252a through inhibiting MLK3/MKK7/JNK3 signaling pathway on ischemic brain injury in rat hippocampal CA1 region. Neuroscience 131, 147-159.
25. Pawson T. and Scott J. D. (1997) Signaling through scaffold, anchoring, and adaptor proteins. Science 278, 2075-2080.
26. Pulsinelli W. A. and Brierley J. B. (1979) A new model of bilateral hemispheric ischemia in the unanesthetized rat. Stroke 10, 267-272.
27. Pulsinelli W. A., Brierley J. B. and Plum F. (1982) Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann. Neurol. 11, 491-498.
28. Rosenbaum D. M., D'Amore J., Llena J., Rybak S., Balkany A. and Kessler J. A. (1998) Pretreatment with intraventricular aurintricarboxylic acid decreases infarct size by inhibiting apoptosis following transient global ischemia in gerbils. Ann. Neurol. 43, 654-660.
29. Saporito M. S., Hudkins R. L. and Maroney A. C. (2002) Discovery of CEP-1347/KT-7515, an inhibitor of the JNK/SAPK pathway for the treatment of neurodegenerative diseases. Prog. Med. Chem. 40, 23-62.
30. Tanaka H., Grooms S. Y., Bennett M. V. and Zukin R. S. (2000) The AMPAR subunit GluR2: still front and center-stage. Brain Res. 886, 190-207.
31. Tapon N., Nagata K., Lamarche N. and Hall A. (1998) A new rac target POSH is an SH3-containing scaffold protein involved in the JNK and NF-κB signalling pathways. EMBO J. 17, 1395-1404.
32. Tournier C., Hess P., Yang D. D., Xu J., Turner T. K., Nimnual A., Bar-Sagi D., Jones S. N., Flavell R. A. and Davis R. J. (2000) Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 288, 870-874.
33. Wang L. H., Besirli C. G. and Johnson E. M. Jr (2004) Mixed-lineage kinases: a target for the prevention of neurodegeneration. Annu. Rev. Pharmacol. Toxicol. 44, 451-474.
34. Wang R. M., Zhang Q. G., Li C. H. and Zhang G. Y. (2005) Activation of extracellular signal-regulated kinase 5 may play a neuroprotective role in hippocampal CA3/DG region after cerebral ischemia. J. Neurosci. Res. 80, 391-399.
35. Whitmarsh A. J., Kuan C. Y., Kennedy N. J. et al. (2001) Requirement of the JIP1 scaffold protein for stress-induced JNK activation. Genes Dev. 15, 2421-2432.
36. Xu Z., Kukekov N. V. and Greene L. A. (2003) POSH acts as a scaffold for a multiprotein complex that mediates JNK activation in apoptosis. EMBO J. 22, 252-261.
37. Yasuda J., Whitmarsh A. J., Cavanagh J., Sharma M. and Davis R. J. (1999) The JIP group of mitogen-activated protein kinase scaffold proteins. Mol. Cell Biol. 19, 7245-7254.
38. Yin X. H., Zhang Q. G., Miao B. and Zhang G. Y. (2005) Neuroprotective effects of preconditioning ischaemia on ischaemic brain injury through inhibition of mixed-lineage kinase 3 via NMDA receptor-mediated Akt1 activation. J. Neurochem. 93, 1021-1029.
39. Zablocka B., Dluzniewska J., Zajac H. and Domanska-Janik K. (2003) Opposite reaction of ERK and JNK in ischemia vulnerable and resistant regions of hippocampus: involvement of mitochondria. Brain Res. Mol. Brain Res. 110, 245-252.
40. Zhang H. and Gallo K. A. (2001) Autoinhibition of mixed lineage kinase 3 through its Src homology 3 domain. J. Biol. Chem. 276, 45 598-45 603.
41. Zhang C., Shen W. and Zhang G. (2002) N-methyl-D-aspartate receptor and 1-type voltage-gated Ca(2+) channel antagonists suppress the release of cytochrome c and the expression of procaspase-3 in rat hippocampus after global brain ischemia. Neurosci. Lett. 328, 265-268.
42. Zheng Z., Zhao H., Steinberg G. K. and Yenari M. A. (2003) Cellular and molecular events underlying ischemia-induced neuronal apoptosis. Drug News Perspect. 16, 497-503.